Vanguard Capital Wealth Advisors Bristol Myers Squibb CO Transaction History

Vanguard Capital Wealth Advisors

$146 Million
Q2 2024

A detailed history of Vanguard Capital Wealth Advisors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Vanguard Capital Wealth Advisors holds 7,500 shares of BMY stock, worth $381,900. This represents 0.21% of its overall portfolio holdings.

Number of Shares

7,500

Previous 7,800 3.85%

Holding current value

$381,900

Previous $422,000 26.3%

% of portfolio

0.21%

Previous 0.3%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$40.25 - $52.99 $12,075 - $15,897	-300 Reduced 3.85%	7,500 $311,000
Q1 2024 Apr 15, 2024	SELL	$47.98 - $54.4 $23,990 - $27,200	-500 Reduced 6.02%	7,800 $422,000
Q4 2023 Feb 05, 2024	BUY	$48.48 - $57.85 $208,464 - $248,755	4,300 Added 107.5%	8,300 $425,000
Q2 2023 Jul 14, 2023	SELL	$63.71 - $70.74 $76,452 - $84,888	-1,200 Reduced 23.08%	4,000 $255,000
Q1 2023 Apr 20, 2023	BUY	$65.71 - $74.53 $111,706 - $126,701	1,700 Added 48.57%	5,200 $360,000
Q4 2022 Jan 17, 2023	BUY	$68.48 - $81.09 $239,680 - $283,815	3,500 New	3,500 $0
Q2 2022 Aug 04, 2022	SELL	$72.62 - $79.98 $428,458 - $471,882	-5,900 Reduced 68.6%	2,700 $207,000
Q1 2022 Apr 29, 2022	SELL	$61.48 - $73.72 $67,628 - $81,092	-1,100 Reduced 11.34%	8,600 $628,000
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $18,770 - $21,882	350 Added 3.74%	9,700 $604,000
Q3 2021 Nov 01, 2021	BUY	$59.17 - $69.31 $122,422 - $143,402	2,069 Added 28.42%	9,350 $553,000
Q2 2021 Jul 28, 2021	SELL	$61.91 - $67.42 $85,064 - $92,635	-1,374 Reduced 15.88%	7,281 $486,000
Q1 2021 Apr 12, 2021	BUY	$59.34 - $66.74 $307,440 - $345,779	5,181 Added 149.14%	8,655 $546,000
Q4 2020 Jan 25, 2021	SELL	$57.74 - $65.43 $159,766 - $181,044	-2,767 Reduced 44.34%	3,474 $215,000
Q2 2020 Aug 05, 2020	SELL	$54.82 - $64.09 $514,376 - $601,356	-9,383 Reduced 60.06%	6,241 $367,000
Q4 2019 Jan 28, 2020	BUY	$49.21 - $64.19 $21,947 - $28,628	446 Added 2.94%	15,624 $1 Million
Q3 2019 Oct 18, 2019	SELL	$42.77 - $50.71 $153,159 - $181,592	-3,581 Reduced 19.09%	15,178 $769,000
Q2 2019 Aug 05, 2019	BUY	$44.62 - $49.34 $41,541 - $45,935	931 Added 5.22%	18,759 $850,000
Q1 2019 Apr 29, 2019	BUY	$45.12 - $53.8 $328,022 - $391,126	7,270 Added 68.86%	17,828 $850,000
Q4 2018 Jan 17, 2019	SELL	$48.76 - $63.23 $84,842 - $110,020	-1,740 Reduced 14.15%	10,558 $548,000
Q3 2018 Oct 19, 2018	BUY	$55.19 - $62.25 $678,726 - $765,550	12,298 New	12,298 $763,000
Q1 2018 Apr 25, 2018	SELL	$59.92 - $68.98 $266,644 - $306,961	-4,450 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$59.94 - $65.35 $266,733 - $290,807	4,450	4,450 $0

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Capital Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Capital Wealth Advisors with notifications on news.

Account

Vanguard Capital Wealth Advisors Bristol Myers Squibb CO Transaction History